Discovery Value Fund Buys 1,710 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Discovery Value Fund raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,442 shares of the medical equipment provider’s stock after purchasing an additional 1,710 shares during the quarter. Intuitive Surgical comprises approximately 1.6% of Discovery Value Fund’s holdings, making the stock its 7th biggest holding. Discovery Value Fund’s holdings in Intuitive Surgical were worth $13,870,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Manchester Financial Inc. bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $25,000. Icon Wealth Partners LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $26,000. Stone House Investment Management LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $31,000. Advisory Alpha LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $32,000. Finally, Ellis Investment Partners LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $34,000. Institutional investors own 86.22% of the company’s stock.

A number of brokerages have recently weighed in on ISRG. Cantor Fitzgerald set a $620.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Friday, July 19th. ValuEngine downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, July 12th. Citigroup decreased their target price on shares of Intuitive Surgical from $611.00 to $575.00 and set a “buy” rating for the company in a research report on Tuesday, May 14th. BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, April 21st. Finally, Morgan Stanley set a $620.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Friday, July 19th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $579.92.

In related news, VP Marshall Mohr sold 15,000 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $526.11, for a total transaction of $7,891,650.00. Following the completion of the sale, the vice president now directly owns 20,135 shares of the company’s stock, valued at approximately $10,593,224.85. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Curet Myriam sold 4,974 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $532.14, for a total transaction of $2,646,864.36. Following the transaction, the executive vice president now owns 3,851 shares of the company’s stock, valued at $2,049,271.14. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 25,882 shares of company stock valued at $13,664,919. 1.70% of the stock is owned by insiders.

ISRG stock opened at $513.60 on Monday. The business has a 50 day simple moving average of $525.92. The company has a market capitalization of $59.19 billion, a P/E ratio of 54.12, a price-to-earnings-growth ratio of 3.82 and a beta of 1.12. Intuitive Surgical, Inc. has a 12 month low of $430.24 and a 12 month high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $1.02. The business had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.03 billion. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. Intuitive Surgical’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.76 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 10.15 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: What is quantitative easing?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.